First Denosumab Biosimilar Approved in Two Different FormulationsMarch 6, 2024OsteoporosisOncologyRheumatologyEndocrinologyLymphoma & Plasma Cell DisordersGenitourinary CancerBreast Cancer
Osteoporosis Drug Denosumab May Confer Lower Risk for DiabetesMarch 4, 2024OsteoporosisDiabetesEndocrinologyRheumatology
Study: Healthy Plant-Based Diets Do Not Raise Hip Fracture RiskFebruary 29, 2024OsteoporosisWomen's HealthDigestive HealthGeriatrics
Calcium Pyrophosphate Deposition Disease Nearly Doubles Fracture RiskFebruary 6, 2024OsteoporosisRheumatology
Vibrating Belt Receives Approval to Help Women With Osteopenia Keep Bone StrengthJanuary 25, 2024EndocrinologyWomen's HealthRheumatologyOsteoporosis
Hypocalcemia Risk Warning Added to Osteoporosis DrugJanuary 22, 2024OsteoporosisRheumatologyNephrologyEndocrinology
Bariatric surgery, including sleeve gastrectomy, linked to fracture riskOctober 25, 2023OsteoporosisGastroenterologyObesityEndocrinology
Tricyclics may raise fracture risk in type 2 diabetesOctober 25, 2023OsteoporosisDiabetesEndocrinologyRheumatologyDepression
Treatment order evidence comes to light for premenopausal idiopathic osteoporosis: What to do after denosumabOctober 23, 2023OsteoporosisWomen's HealthEndocrinology
Greater fracture risk reduction seen with denosumab vs. zoledronic acid in postmenopausal womenOctober 17, 2023OsteoporosisPreventive CareEndocrinologyWomen's Health